Table 3.
Comparison of CriSTAL performance and predictors with other 3-month prediction tools
| Country, date, reference, prediction timeframe | Patient type and predictors | AUROC | 95% CI |
|---|---|---|---|
| Australia 2016a | 65+ years-multimorbidity, ED Male, old age, cancer, frailty |
0.81 | 0.76–0.86 |
| Denmark 2016a | 65+ years-multimorbidity, ED Male, old age, cancer, frailty, oxygen saturation |
0.79 | 0.76–0.84 |
| France 2015 [26] | Older patients with CKD Male, old age, poor mobility, cancer |
0.76 | 0.75–0.77 |
| Holland 2012 [8] | 70+ years, ED patients Disease severity, functional/cognitive impairment |
0.74 | 0.67–0.80 |
| Japan 2015 [27] | Patients on terminal chemotherapy 40 + lab tests: Alb, LDH, neurtrophil count |
0.77 | N/R |
| USA 2012 [31] | 60+ year with end-stage liver disease Modified frailty index, serum sodium |
0.82 | N/R |
| Holland 2016 [28] | Older patients discharged from ED Low oxygen saturation, old age |
N/R | N/R |
| Brazil 2008 [29] | Older patients post-hip fracture Old age, Charlson multimorbidity |
N/R | N/R |
| Italy 2013 [30] | Cognitively impaired older persons Cancer and hospital adverse event |
N/R | N/R |
| USA 2016 [32] | 55+ year adults in ED Palliative performance score |
N/R | N/R |
aThis study ED emergency department patients, CKD chronic kidney disease, N/R not reported